CORCEPT THERAPEUTICS INC financial data

Symbol
CORT on Nasdaq
Location
Redwood City, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 04 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 315% % -32%
Quick Ratio 9% % 17%
Debt-to-equity 26% % 22%
Return On Equity 16% % -35%
Return On Assets 13% % -37%
Operating Margin 9% % -61%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 105,188,217 shares 0.39%
Common Stock, Shares, Outstanding 105,113,000 shares 1.7%
Entity Public Float $2,691,187,787 USD 47%
Common Stock, Value, Issued $139,000 USD 3%
Weighted Average Number of Shares Outstanding, Basic 103,545,000 shares 0.17%
Weighted Average Number of Shares Outstanding, Diluted 119,439,000 shares 5%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $741,172,000 USD 18%
Research and Development Expense $260,353,000 USD 13%
Costs and Expenses $675,601,000 USD 39%
Operating Income (Loss) $65,571,000 USD -54%
Nonoperating Income (Expense) $22,943,000 USD -0.16%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $88,514,000 USD -47%
Income Tax Expense (Benefit) $17,596,000 USD -172%
Net Income (Loss) Attributable to Parent $106,110,000 USD -25%
Earnings Per Share, Basic 1 USD/shares -26%
Earnings Per Share, Diluted 0 USD/shares -30%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $125,138,000 USD -8.9%
Marketable Securities, Current $296,545,000 USD 22%
Accounts Receivable, after Allowance for Credit Loss, Current $69,629,000 USD 17%
Inventory, Net $12,349,000 USD 53%
Other Assets, Current $5,999,000 USD 31%
Assets, Current $541,130,000 USD 16%
Deferred Income Tax Assets, Net $152,999,000 USD 21%
Property, Plant and Equipment, Net $2,094,000 USD -29%
Operating Lease, Right-of-Use Asset $4,776,000 USD -13%
Other Assets, Noncurrent $8,049,000 USD 15%
Assets $823,607,000 USD 5%
Accounts Payable, Current $34,446,000 USD 85%
Accrued Liabilities, Current $108,447,000 USD 36%
Liabilities, Current $172,265,000 USD 36%
Accrued Income Taxes, Noncurrent $14,132,000 USD 10%
Operating Lease, Liability, Noncurrent $5,308,000 USD -17%
Liabilities $191,705,000 USD 32%
Accumulated Other Comprehensive Income (Loss), Net of Tax $2,341,000 USD 49%
Retained Earnings (Accumulated Deficit) $619,099,000 USD 21%
Stockholders' Equity Attributable to Parent $631,902,000 USD -1.1%
Liabilities and Equity $823,607,000 USD 5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $5,128,000 USD -78%
Net Cash Provided by (Used in) Financing Activities $39,803,000 USD -7230%
Net Cash Provided by (Used in) Investing Activities $3,171,000 USD 65%
Common Stock, Shares Authorized 280,000,000 shares 0%
Common Stock, Shares, Issued 137,753,000 shares 2.5%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $37,846,000 USD -367%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $125,138,000 USD -8.9%
Deferred Tax Assets, Valuation Allowance $17,460,000 USD 9.5%
Deferred Tax Assets, Gross $149,675,000 USD 39%
Operating Lease, Liability $6,358,000 USD -6.4%
Payments to Acquire Property, Plant, and Equipment $104,000 USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $106,880,000 USD -26%
Lessee, Operating Lease, Liability, to be Paid $7,732,000 USD -11%
Operating Lease, Liability, Current $1,050,000 USD 143%
Lessee, Operating Lease, Liability, to be Paid, Year Two $1,598,000 USD 3%
Lessee, Operating Lease, Liability, to be Paid, Year One $1,551,000 USD 12%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Deferred Income Tax Expense (Benefit) $13,705,000 USD -91%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1,374,000 USD -29%
Lessee, Operating Lease, Liability, to be Paid, Year Three $1,646,000 USD 3%
Deferred Tax Assets, Operating Loss Carryforwards $3,470,000 USD -12%
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $16,449,000 USD 26%
Lessee, Operating Lease, Liability, to be Paid, Year Four $1,695,000 USD 3%
Operating Lease, Payments $1,000,000 USD -49%
Additional Paid in Capital $832,108,000 USD 13%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $52,000 USD -56%
Depreciation, Depletion and Amortization $285,000 USD 138%
Deferred Tax Assets, Net of Valuation Allowance $130,914,000 USD 44%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%